The IMARC Group provides extensive analysis of the antihypertensive drugs market covering the market trends, investment opportunities, growth trends, statistics, and industry prospects. The report also provides competitor analysis, regional analysis, and recent advancements in the global market.
We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report. The market is segmented by species, size and region. The report provides an analysis of the key trends in each sub-segment of the market, along with forecasts at the global and regional level from 2022-2027. The report also includes competitive landscape of major key players in the industry along with emerging trends in the market.
Informed covered in the report:
- Historical market data from 2016-2021
- CAGR of the market during the forecast period 2022-2027
- Detailed information on factors that will drive market growth during the next five years
- Precise estimation of the antihypertensive drugs market size and its contribution to the parent market
- Upcoming market trends and changes in consumer behavior
- A thorough analysis of the market’s competitive landscape and detailed information on key players
- Comprehensive details of factors that will challenge the growth of smart meters market key players
Request Free Sample Report: https://www.imarcgroup.com/antihypertensive-drugs-market/requestsample
Antihypertensive drugs refer to therapeutic medications that are used to prevent, control, and treat hypertension and high blood pressure problems. They include diuretics, angiotensin-converting enzyme inhibitors, vasodilators, beta-blockers, calcium channel blockers, etc. Antihypertensive drugs assist in removing excess fluids and salts and in relaxing and broadening the blood vessels. They also aid in maintaining healthy systolic blood pressure by slowing down the heartbeat and can be given orally or through intravenous injections. Consequently, antihypertensive drugs are widely utilized in hospitals, clinics, rehabilitation facilities, ambulatory surgery centers, etc., across the globe.
The increasing prevalence of cardiovascular disorders and hypertension is among the primary factors augmenting the antihypertensive drugs market. Moreover, the expanding geriatric population, who are more prone to numerous heart illnesses, is further propelling the market growth. Apart from this, the elevating number of patients suffering from hypertension and high blood pressure, owing to the sedentary lifestyles and unhealthy dietary patterns of individuals, is acting as another significant growth-inducing factor. Furthermore, the launch of imidazolines, monatepil, and neutral endopeptidase inhibitors is also positively influencing the global market for antihypertensive drugs. In addition to this, the inflating healthcare expenditures and the extensive research and development (R&D) activities are projected to catalyze the antihypertensive drugs market over the forecasted period.
Key Market Segmentation:
Some of these key players include:
- Boehringer Ingelheim International GmbH
- Daiichi Sankyo Company Limited
- Johnson & Johnson Services Inc.
- Lupin Pharmaceuticals Inc
- Merck & Co. Inc.
- Novartis AG
- Pfizer Inc.
- Sanofi and Sun Pharmaceutical Industries Ltd.
Breakup by Therapeutic Class:
- ACE Inhibitors
- Calcium Channel Blockers
- Beta-adrenergic Blockers
Breakup by Type:
- Primary hypertension
- Secondary Hypertension
Breakup by Distribution Channel:
- Retail Pharmacy
- Hospital Pharmacy
Breakup by Region:
- Middle East and Africa
- North America
- Latin America
Key highlights of the report:
- Market Performance (2016-2021)
- Market Outlook (2022- 2027)
- Porter’s Five Forces Analysis
- Market Drivers and Success Factors
- SWOT Analysis
- Value Chain
- Comprehensive Mapping of the Competitive Landscape
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.
30 N Gould St Ste R
Sheridan, WY 82801 USA
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800
Read More- https://reflectionbusiness.com/